FWRD:NASDAQForward Air Corporation Analysis
Data as of 2026-05-23 - not real-time
$8.80
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Forward Air (FWRD) is trading at $8.80, well below its 20‑day SMA of $13.85, 50‑day SMA of $16.56 and 200‑day SMA of $23.21, indicating a strong bearish price trend. The 14‑day RSI of 28.2 suggests the stock is oversold, while the MACD line sits at -3.14 with a bearish histogram, reinforcing downside momentum. Current price hovers just above the identified support level of $7.86 and far from the resistance at $23.90, limiting immediate upside potential. Volatility is extreme at 195% over the past 30 days and beta is nearly 2.0, pointing to amplified price swings relative to the market.
Fundamentally, the company reports a negative profit margin of -3.7% and a trailing EPS of -$2.92, with a debt‑to‑equity ratio exceeding 1,700%, indicating severe leverage concerns. Cash on hand ($141 M) is insufficient to offset the $2.15 B debt load, and free cash flow, though positive, is modest at $55.9 M. The price‑to‑book ratio of 3.43 and a forward PE of -34.7 imply the market is pricing in significant risk despite the “Buy” consensus from analysts. Upcoming Q1 2026 earnings could catalyze short‑term moves, but the combination of technical weakness and financial strain suggests caution.
Fundamentally, the company reports a negative profit margin of -3.7% and a trailing EPS of -$2.92, with a debt‑to‑equity ratio exceeding 1,700%, indicating severe leverage concerns. Cash on hand ($141 M) is insufficient to offset the $2.15 B debt load, and free cash flow, though positive, is modest at $55.9 M. The price‑to‑book ratio of 3.43 and a forward PE of -34.7 imply the market is pricing in significant risk despite the “Buy” consensus from analysts. Upcoming Q1 2026 earnings could catalyze short‑term moves, but the combination of technical weakness and financial strain suggests caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical indicators (price below all SMAs, negative MACD)
- Oversold RSI may limit immediate downside
- Upcoming earnings release adds uncertainty
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Heavy debt burden (Debt/Equity > 1,700%)
- Modest free cash flow versus large leverage
- Valuation metrics (P/B 3.43, negative earnings) remain unattractive
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained negative profitability and low ROE
- High volatility and beta increasing price risk
- Sector cyclicality and potential regulatory pressures
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin-3.71%
P/E Ratio-34.7
ROE-69.13%
ROA2.10%
Debt/Equity1758.63
P/B Ratio3.4
Op. Cash Flow$62.5M
Free Cash Flow$55.9M
Industry P/E29.7
Technical Analysis
TrendBearish
RSI28.2
Support$7.86
Resistance$23.90
MA 20$13.85
MA 50$16.56
MA 200$23.21
MACDBearish
VolumeStable
Fear & Greed Index91.61
Valuation
Target Price$18.33
Upside/Downside108.33%
GradeOvervalued
TypeValue
Risk Assessment
Beta1.98
Volatility195.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.